1-(carboxymethylthio)tetradecane has been researched along with Chronic Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berge, K; Berge, RK; Bjørndal, B; Bohov, P; Burri, L; Svardal, A; Wergedahl, H | 1 |
1 other study(ies) available for 1-(carboxymethylthio)tetradecane and Chronic Disease
| Article | Year |
|---|---|
Tetradecylthioacetic acid increases hepatic mitochondrial β-oxidation and alters fatty acid composition in a mouse model of chronic inflammation.
Topics: Animals; Antioxidants; Chronic Disease; Diet; Fatty Acids; Female; Humans; Inflammation; Lipids; Mice; Mice, Transgenic; Mitochondria, Liver; Oxidation-Reduction; Rats; Sulfides; Tumor Necrosis Factor-alpha | 2011 |